1
|
Reolão BR, Mora DS, Garcia MCDS, Bonamigo RR. Breast carcinoma metastasis and Wolf's isotopic response. An Bras Dermatol 2022; 97:467-470. [PMID: 35676106 PMCID: PMC9263666 DOI: 10.1016/j.abd.2021.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 10/11/2021] [Accepted: 10/24/2021] [Indexed: 11/29/2022] Open
Abstract
Wolf's isotopic phenomenon occurs when a new dermatosis appears on a site that has already healed from a previous dermatological disease of another etiology. This report describes the case of a 44-year-old female patient undergoing treatment for breast carcinoma who recently had brownish erythematous lesions appearing on the scar region of previous herpes zoster on the right hemithorax. Histopathology and immunohistochemistry examination confirmed skin metastasis of breast cancer. Herpes zoster scars require attention due to the possibility of an isotopic response as a facilitating factor in some dermatoses, sometimes severe ones, such as neoplasms.
Collapse
Affiliation(s)
| | | | | | - Renan Rangel Bonamigo
- Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil; Ambulatório de Dermatologia Sanitária do Rio Grande do Sul, Porto Alegre, RS, Brazil; Faculty of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| |
Collapse
|
2
|
González-Martínez S, Pizarro D, Pérez-Mies B, Caniego-Casas T, Curigliano G, Cortés J, Palacios J. Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis. Cancers (Basel) 2021; 13:5416. [PMID: 34771579 PMCID: PMC8582578 DOI: 10.3390/cancers13215416] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 10/25/2021] [Accepted: 10/26/2021] [Indexed: 12/20/2022] Open
Abstract
Cutaneous metastases (CMs) account for 2% of all skin malignancies, and nearly 70% of CMs in women originate from breast cancer (BC). CMs are usually associated with poor prognosis, are difficult to treat, and can pose diagnostic problems, such as in histopathological diagnosis when occurring long after development of the primary tumor. In addition, the molecular differences between the primary tumors and their CMs, and between CMs and metastases in other organs, are not well defined. Here, we review the main clinical, pathological, and molecular characteristics of breast cancer CMs. Identifying molecular markers in primary BC that predict CM and can be used to determine the molecular differences between primary tumors and their metastases is of great interest for the design of new therapeutic approaches.
Collapse
Affiliation(s)
- Silvia González-Martínez
- Clinical Researcher, Hospital Ramón y Cajal, 28034 Madrid, Spain;
- Fundación Contigo contra el Cáncer de la Mujer, 28010 Madrid, Spain
| | - David Pizarro
- Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain; (D.P.); (B.P.-M.); (T.C.-C.)
| | - Belén Pérez-Mies
- Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain; (D.P.); (B.P.-M.); (T.C.-C.)
- Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain
- CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain
- Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain
| | - Tamara Caniego-Casas
- Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain; (D.P.); (B.P.-M.); (T.C.-C.)
| | - Giuseppe Curigliano
- European Institute of Oncology, IRCCS, 20141 Milan, Italy;
- Departament of Oncology and Hematology, University of Milan, 20122 Milan, Italy
| | - Javier Cortés
- CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain
- Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670 Madrid, Spain
- International Breast Cancer Center (IBCC), Quironsalud Group, 08017 Barcelona, Spain
- Medica Scientia Innovation Research, 08007 Barcelona, Spain
- Medica Scientia Innovation Research, Ridgewood, NJ 07450, USA
- Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain
| | - José Palacios
- Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain; (D.P.); (B.P.-M.); (T.C.-C.)
- Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain
- CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain
- Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain
| |
Collapse
|
3
|
Chraiet N, Zenzri Y, Bouaziz H, Sassi I, Guebsi A, Kamoun S, Rahal K, Mezlini A. Generalized cutaneous metastases of breast cancer: An uncommon presentation. Clin Case Rep 2020; 8:667-671. [PMID: 32274032 PMCID: PMC7141747 DOI: 10.1002/ccr3.2693] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2019] [Revised: 12/16/2019] [Accepted: 01/09/2020] [Indexed: 11/27/2022] Open
Abstract
Cutaneous metastases are rare and represent a sign of poor prognosis. They are a sign of widespread disease. Breast cancer is the most common neoplasm leading to their appearance. Palliative care is the treatment of choice.
Collapse
Affiliation(s)
- Nesrine Chraiet
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Yosr Zenzri
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Hanen Bouaziz
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Imen Sassi
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Azza Guebsi
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Salma Kamoun
- Pathology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Khaled Rahal
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Amel Mezlini
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| |
Collapse
|